http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006517940-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02 |
| filingDate | 2004-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2006-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2006517940-A |
| titleOfInvention | Use of R-10-hydroxy-10,11-dihydro-carbamazepine in neuropathic pain |
| abstract | The present invention relates to a compound of formula I for the manufacture of a pharmaceutical composition for the treatment of neuropathic pain. [Chemical 1] At least 55%, most preferably at least 98% of the R-enantiomer and not more than 45%, most preferably not more than 2% of the enantiomer of the compound or a pharmaceutically acceptable salt of said enantiomer. Use of a mixture of enantiomers; Treatment of neuropathic pain; And a mixture comprising at least 55% R-enantiomer and no more than 45% S-enantiomer of an enantiomer of a compound of formula I or a pharmaceutically acceptable salt of said enantiomer as an active agent . |
| priorityDate | 2003-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 37.